Personalized Combination Therapy May Improve Outcomes in Refractory Malignant Disease
Razelle Kurzrock, Professor and Associate Director of Clinical Research at the Medical College of Wisconsin Cancer Center, explains in this MEDtalk that personalised medicine can be optimised by treating molecularly complex and heterogeneous cancers with combinations of tailored therapies.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
